Key result
Combining NCX blockade with postconditioning abolished cardioprotection in isolated mouse hearts despite phosphorylation of ERK1/2 (P=0.03) and PKCepsilon (P=0.01).
Why the study?
Does combining NCX blockade with ischemic postconditioning reduce infarct size in isolated mouse hearts subjected to ischemia-reperfusion?
Does combining NCX blockade with ischemic postconditioning reduce infarct size in isolated mouse hearts subjected to ischemia-reperfusion?
Combining NCX blockade with ischemic postconditioning abolishes the cardioprotective effects seen with either intervention alone in isolated mouse hearts.
NCX required for postconditioning protection despite kinase activation in mouse hearts; leaves open therapeutic targeting pending human studies.
Ischemic postconditioning and inhibition of the reverse mode of the sodium-calcium exchanger (NCX) are both cardioprotective. We hypothesized that a combination of these techniques might have an additive effect mediated by protein kinases (see below). Isolated perfused mouse hearts were subjected to 35 min of ischemia and 60 min of reperfusion. Each series had its own control ischemia group, the other groups were postconditioning with three cycles of 10 s of reperfusion and 10 s of ischemia immediately after sustained ischemia; the vehicle of the NCX blocker KB-R7943 was added to the perfusate 5 min before ischemia in series 1; KB-R7943 was added to the perfusate 5 min before ischemia with and without postconditioning in series 2; KB-R7943 was added to the perfusate for 5 min from the start of reperfusion with and without postconditioning in series 3. Infarct size was measured and cardiac function was evaluated. Phosphorylation of AKT, ERK1/2, PKCdelta and PKCepsilon was measured by immunoblotting. Postconditioning alone reduced infarct size by 37% and activated AKT (P=0.02). Blockade of NCX reduced infarct size when applied before ischemia (29%) and at start of reperfusion (32%). Combining NCX blockade with postconditioning abolished cardioprotection despite phosphorylation of ERK1/2 (P=0.03) and PKCepsilon (P=0.01).
No takes yet. Share an insight, caveat, or question.
Kaljusto et al. (2010) studied Ischemia/reperfusion injury. Postconditioning combined with NCX blocker KB-R7943 vs. Control ischemia, postconditioning alone, or NCX blockade alone was evaluated on Infarct size. Combining NCX blockade with postconditioning abolished cardioprotection in isolated mouse hearts despite phosphorylation of ERK1/2 (P=0.03) and PKCepsilon (P=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: